RAMM Pharma Corp.

RAMM Pharma Corp., established in Toronto, Canada, in 1987, focuses on the comprehensive lifecycle of various health and wellness products. The company is engaged in the creation, manufacturing, and distribution of cannabinoid-based pharmaceutical drugs, conventional medications, beauty products, nutritional supplements, and also resells medical equipment to both Canadian and international markets. Its portfolio features key products such as Epifractán, a cannabinoid-infused pharmaceutical; XALEX 10, a prescription formulation designed to treat stubborn cases of epilepsy; and NettaLife, a cannabis-derived product specifically for pets. The firm adopted its current name, RAMM Pharma Corp., in October 2019, having previously operated as MTC Growth Fund-I Inc.